Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target
Non-communicable diseases (NCDs), represented by cardiovascular diseases and cancer, have been the leading cause of death globally. Improvements in mortality from cardiovascular (CV) diseases (decrease of 14%/100,000, United States) or cancers (increase 7.5%/100,000, United States) seem unsatisfacto...
Main Authors: | Qianru Leng, Jie Ding, Meiyan Dai, Lei Liu, Qing Fang, Dao Wen Wang, Lujin Wu, Yan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.879351/full |
Similar Items
-
Comprehensive Characterization of Platelet-Enriched MicroRNAs as Biomarkers of Platelet Activation
by: Teresa L. Krammer, et al.
Published: (2022-04-01) -
microRNAs as Promising Biomarkers of Platelet Activity in Antiplatelet Therapy Monitoring
by: Teresa L. Krammer, et al.
Published: (2020-05-01) -
Effect of acetylsalicylic acid intake on platelet derived microvesicles in healthy subjects
by: Justyna Rosinska, et al.
Published: (2020-02-01) -
microRNAs Are Abundant and Stable in Platelet-Rich Fibrin and Other Autologous Blood Products of Canines
by: Indre Jasineviciute, et al.
Published: (2023-01-01) -
Contribution of platelet-derived microRNAs to serum microRNAs in healthy men
by: Ichiro Wakabayashi, et al.
Published: (2021-10-01)